Shan, Yibing <br/><br/>
Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization.  [electronic resource] 

 -  Cell  May 2012 
 - 860-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1097-4172 
<br/><br/><label>Standard No.: </label>10.1016/j.cell.2012.02.063  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Crystallography, X-Ray<br/>ErbB Receptors--antagonists & inhibitors<br/>Gefitinib<br/>Humans<br/>Lapatinib<br/>Molecular Dynamics Simulation<br/>Molecular Sequence Data<br/>Neoplasms--metabolism<br/>Point Mutation<br/>Protein Folding<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Multimerization<br/>Protein Structure, Tertiary<br/>Quinazolines--pharmacology<br/>Sequence Alignment<br/>Signal Transduction